Signaturefd, LLC Next Cure, Inc. Transaction History

Signaturefd, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 28, 2021	SELL	$6.74 - $8.02 $633 - $753	-94 Closed	0 $0
Q2 2021 Jul 26, 2021	SELL	$7.6 - $10.28 $1,877 - $2,539	-247 Reduced 72.43%	94 $1,000
Q1 2021 Apr 30, 2021	BUY	$9.81 - $13.88 $3,345 - $4,733	341 New	341 $3,000
Q3 2020 Nov 03, 2020	SELL	$8.15 - $21.17 $383 - $994	-47 Closed	0 $0
Q2 2020 Jul 30, 2020	BUY	$21.19 - $40.2 $995 - $1,889	47 New	47 $1,000

15.9M

Ticker NXTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,748,800
Market Cap $36.4M
Description
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase II clinical trials for the treatment of advanced or metastatic solid tumors. The comp...

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

Stay updated on Signaturefd, LLC with notifications on news.